Description |
1 online resource (ii, 34 pages) : color illustrations |
|
text rdacontent |
|
computer rdamedia |
|
online resource rdacarrier |
Note |
Title from title screen (viewed on July 5, 2013). |
|
"April 2013." |
Summary |
PEPFAR, first authorized in 2003, has supported significant advances in HIV/AIDS prevention, treatment, and care in over 30 countries, including directly supporting treatment for about 5.1 million people; however, millions more people still need treatment. PEPFAR has allocated more than half of its funding to care and treatment and has spent over $1.2 billion to purchase ARV drugs. In addition to supplying ARV drugs directly in some countries, PEPFAR also helps partner countries manage their drug supply chains. GAO was asked to review PEPFAR supported ARV drug supply chains. GAO examined (1) actions PEPFAR has taken regarding ARV drug supply chains and (2) partner-country ARV drug supply chain operations. GAO reviewed PEPFAR and the U.S. Agency for International Development (USAID) guidance and supply chain studies; analyzed 16 supply chain evaluations conducted in seven countries and published in 2011 and 2012; interviewed officials from OGAC, USAID, and other agencies; and conducted fieldwork in three countries selected on the basis of program size and other factors. |
Bibliography |
Includes bibliographical references. |
Note |
"GAO-13-483." |
File Type |
Text in PDF format. |
System Details |
Mode of access: World Wide Web. |
|
System requirements: Adobe Acrobat reader. |
Subject |
United States. President's Emergency Plan for AIDS Relief.
|
|
AIDS (Disease) -- Prevention -- Government policy -- United States.
|
|
HIV infections -- Prevention -- Government policy -- United States.
|
|
AIDS (Disease) -- Prevention -- International cooperation.
|
|
HIV infections -- Prevention -- International cooperation.
|
|
Medical assistance, American -- Costs.
|
|
United States. President's Emergency Plan for AIDS Relief. |
|
HIV Infections -- drug therapy -- Statistics. |
|
Acquired Immunodeficiency Syndrome -- drug therapy -- Statistics. |
Added Title |
Drug supply chains are stronger, but more steps are needed to reduce risks |
Running Title |
PEPFAR supply chains |
Gpo Item No. |
0546-D (online) |
Sudoc No. |
GA 1.13:GAO-13-483 |
|